A pilot study to evaluate the effect of CT1812 treatment on synaptic density and other biomarkers in Alzheimer’s disease

被引：0
|
作者：
Christopher H. van Dyck
Adam P. Mecca
Ryan S. O’Dell
Hugh H. Bartlett
Nina G. Diepenbrock
Yiyun Huang
Mary E. Hamby
Michael Grundman
Susan M. Catalano
Anthony O. Caggiano
Richard E. Carson
机构：
[1] Yale University School of Medicine,Alzheimer’s Disease Research Unit, Department of Psychiatry
[2] Yale University,Department of Radiology and Biomedical Imaging
[3] Cognition Therapeutics Inc.,Department of Neurosciences
[4] Global R&D Partners,undefined
[5] LLC,undefined
[6] University of California,undefined
[7] Circle Biopharma,undefined
来源：
Alzheimer's Research & Therapy | / 16卷
关键词：
Alzheimer’s disease; Sigma-2 receptor; Amyloid beta oligomers; SV2A PET; FDG PET; Biomarkers;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] A pilot study to evaluate the effect of CT1812 treatment on synaptic density and other biomarkers in Alzheimer's disease
    van Dyck, Christopher H.
    Mecca, Adam P.
    O'Dell, Ryan S.
    Bartlett, Hugh H.
    Diepenbrock, Nina G.
    Huang, Yiyun
    Hamby, Mary E.
    Grundman, Michael
    Catalano, Susan M.
    Caggiano, Anthony O.
    Carson, Richard E.
    ALZHEIMERS RESEARCH & THERAPY, 2024, 16 (01)
  • [2] A Pilot Electroencephalography Study of the Effect of CT1812 Treatment on Synaptic Activity in Patients with Mild to Moderate Alzheimer's Disease
    Vijverberg, E.
    de Haan, W.
    Scheijbeler, E.
    Hamby, M. E.
    Catalano, S.
    Scheltens, P.
    Grundman, M.
    Caggiano, Anthony O.
    JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2024, 11 (06): : 1809 - 1817
  • [3] CT1812 Exhibits a Synaptoprotective Effect in Alzheimer's Disease Patients
    Catalano, Susan M.
    Schneider, S.
    DeKosky, Steven
    Morgan, Roger
    Rehak, Courtney
    Silky, Colleen
    Mozzoni, Kelsie
    Izzo, Nicholas J.
    Grundman, Michael
    Schirm, Michael
    Guilbaud, Rudolf
    Watson, Mark
    Chelsky, Daniel
    Davis, Charles
    Zetterberg, Henrik
    Blennow, Kaj
    NEUROTHERAPEUTICS, 2018, 15 (03) : 819 - 820
  • [4] Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification
    Izzo, Nicholas J.
    Yuede, Carla M.
    LaBarbera, Kelsie M.
    Limegrover, Colleen S.
    Rehak, Courtney
    Yurko, Raymond
    Waybright, Lora
    Look, Gary
    Rishton, Gilbert
    Safferstein, Hank
    Hamby, Mary E.
    Williams, Claire
    Sadlek, Kelsey
    Edwards, Hannah M.
    Davis, Charles S.
    Grundman, Michael
    Schneider, Lon S.
    DeKosky, Steven T.
    Chelsky, Daniel
    Pike, Ian
    Henstridge, Christopher
    Blennow, Kaj
    Zetterberg, Henrik
    LeVine, Harry, III
    Spires-Jones, Tara L.
    Cirrito, John R.
    Catalano, Susan M.
    ALZHEIMERS & DEMENTIA, 2021, 17 (08) : 1365 - 1382
  • [5] Discovery of Investigational Drug CT1812, an Antagonist of the Sigma-2 Receptor Complex for Alzheimer's Disease
    Rishton, Gilbert M.
    Look, Gary C.
    Ni, Zhi-Jie
    Zhang, Jason
    Wang, Yingcai
    Huang, Yaodong
    Wu, Xiaodong
    Izzo, Nicholas J.
    LaBarbera, Kelsie M.
    Limegrover, Colleen S.
    Rehak, Courtney
    Yurko, Raymond
    Catalano, Susan M.
    ACS MEDICINAL CHEMISTRY LETTERS, 2021, 12 (09): : 1389 - 1395
  • [6] CT1812, a Small Molecule Sigma-2 Receptor Antagonist for Alzheimer's Disease Treatment: A Systematic Review of Available Clinical Data
    Thitilertdecha, Premrutai
    Brimson, James Michael
    JOURNAL OF ALZHEIMERS DISEASE, 2024, 101 : S115 - S128
  • [7] An interim exploratory proteomics biomarker analysis of a phase 2 clinical trial to assess the impact of CT1812 in Alzheimer's disease
    Lizama, B. N.
    North, H. A.
    Pandey, K.
    Williams, C.
    Duong, D.
    Cho, E.
    Di Caro, V.
    Ping, L.
    Blennow, K.
    Zetterberg, H.
    Lah, J.
    Levey, A. I.
    Grundman, M.
    Caggiano, A. O.
    Seyfried, N. T.
    Hamby, M. E.
    NEUROBIOLOGY OF DISEASE, 2024, 199
  • [8] A phase 1b randomized clinical trial of CT1812 to measure Aβ oligomer displacement in Alzheimer's disease using an indwelling CSF catheter
    LaBarbera, Kelsie M.
    Sheline, Yvette I.
    Izzo, Nicholas J.
    Yuede, Carla M.
    Waybright, Lora
    Yurko, Raymond
    Edwards, Hannah M.
    Gardiner, Woodrow D.
    Blennow, Kaj
    Zetterberg, Henrik
    Borjesson-Hanson, Anne
    Morgan, Roger
    Davis, Charles S.
    Guttendorf, Robert J.
    Schneider, Lon S.
    DeKosky, Steven
    LeVine, Harry, III
    Grundman, Michael
    Caggiano, Anthony O.
    Cirrito, John R.
    Catalano, Susan M.
    Hamby, Mary E.
    TRANSLATIONAL NEURODEGENERATION, 2023, 12 (01)
  • [9] Inflammation biomarkers and Alzheimer's disease: A pilot study using NULISAseq
    Di Molfetta, Guglielmo
    Pola, Ilaria
    Tan, Kubra
    Isaacson, Richard
    Blennow, Kaj
    Ashton, Nicholas J.
    Benedet, Andrea L.
    Zetterberg, Henrik
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2025, 17 (01)
  • [10] Peripheral Retinal Imaging Biomarkers for Alzheimer's Disease: A Pilot Study
    Csincsik, Lajos
    MacGillivray, Thomas J.
    Flynn, Erin
    Pellegrini, Enrico
    Papanastasiou, Giorgos
    Barzegar-Befroei, Neda
    Csutak, Adrienne
    Bird, Alan C.
    Ritchie, Craig W.
    Peto, Tunde
    Lengyel, Imre
    OPHTHALMIC RESEARCH, 2018, 59 (04) : 182 - 192
12345